
HistoIndex is a digital pathology company specializing in stain-free AI-based solutions for drug development and clinical diagnosis. Their proprietary technology integrates Second Harmonic Generation (SHG) imaging with AI image analysis to visualize and quantify morphological features like fibrosis in tissues. This approach aims to provide deeper biological insights, accelerate therapeutic development, and improve diagnostic accuracy. They offer services like FibroSIGHT™ for clinical testing, and their technology is used across the drug development value chain, from preclinical studies to clinical trials and diagnostics. HistoIndex has a global presence with offices in Singapore, China, and the UK, and collaborates with numerous academic and industry partners.

HistoIndex is a digital pathology company specializing in stain-free AI-based solutions for drug development and clinical diagnosis. Their proprietary technology integrates Second Harmonic Generation (SHG) imaging with AI image analysis to visualize and quantify morphological features like fibrosis in tissues. This approach aims to provide deeper biological insights, accelerate therapeutic development, and improve diagnostic accuracy. They offer services like FibroSIGHT™ for clinical testing, and their technology is used across the drug development value chain, from preclinical studies to clinical trials and diagnostics. HistoIndex has a global presence with offices in Singapore, China, and the UK, and collaborates with numerous academic and industry partners.